BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lenz K, Buder R, Kapun L, Voglmayr M. Treatment and management of ascites and hepatorenal syndrome: an update. Therap Adv Gastroenterol 2015;8:83-100. [PMID: 25729433 DOI: 10.1177/1756283X14564673] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Krutikov ES, Vostrikova AN, Krutikov SN. Hepatorenal syndrome: new insights about treatment (part III). jour 2022;3:32-39. [DOI: 10.21886/2712-8156-2022-3-4-32-39] [Reference Citation Analysis]
2 Kabolowsky M, Nguyen L, Fortune BE, Santos E, Kishore S, Camacho JC. Interventional Management of Portal Hypertension in Cancer Patients. Curr Oncol Rep 2022;24:1461-75. [PMID: 35953600 DOI: 10.1007/s11912-022-01319-8] [Reference Citation Analysis]
3 Wu HHL, Athwal VS, Kalra PA, Chinnadurai R. COVID-19 and hepatorenal syndrome. World J Gastroenterol 2022; 28(39): 5666-5678 [DOI: 10.3748/wjg.v28.i39.5666] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chaney A. A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis. Clin Exp Gastroenterol 2021;14:385-96. [PMID: 34675586 DOI: 10.2147/CEG.S323778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Petagine L, Zariwala MG, Patel VB. Alcoholic liver disease: Current insights into cellular mechanisms. World J Biol Chem 2021; 12(5): 87-103 [PMID: 34630912 DOI: 10.4331/wjbc.v12.i5.87] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
6 Delik A, Ülger Y. Treatment Approach in Patients with Decompensated Liver Cirrhosis. Advances in Hepatology 2021. [DOI: 10.5772/intechopen.96155] [Reference Citation Analysis]
7 Makar M, Reja D, Chouthai A, Kabaria S, Patel AV. The impact of acute kidney injury on mortality and clinical outcomes in patients with alcoholic cirrhosis in the USA. Eur J Gastroenterol Hepatol 2021;33:905-10. [PMID: 32976187 DOI: 10.1097/MEG.0000000000001947] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhang Y, Liu D, Xue F, Yu H, Wu H, Cui X, Zhang X, Wang H. Anti-Malignant Ascites Effect of Total Diterpenoids from Euphorbiae Ebracteolatae Radix Is Attributable to Alterations of Aquaporins via Inhibiting PKC Activity in the Kidney. Molecules 2021;26:942. [PMID: 33578967 DOI: 10.3390/molecules26040942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Paris JJ, Vallandingham S, Cummings B, Cohen R. The Neonatal Intensive Care Unit: From Aggressive Treatment to Care of the Dying, Insights from Art and Poetry. Camb Q Healthc Ethics 2020;29:354-60. [PMID: 32484132 DOI: 10.1017/S0963180120000079] [Reference Citation Analysis]
10 Lawlor BT, Grodin JL. Hepato-renal Dysfunction in a Patient with Advanced Heart Failure. Cardiorenal Syndrome in Heart Failure 2020. [DOI: 10.1007/978-3-030-21033-5_14] [Reference Citation Analysis]
11 Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol 2019; 25(28): 3738-3752 [PMID: 31391769 DOI: 10.3748/wjg.v25.i28.3738] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
12 Chinese Society of Hepatology, Chinese Medical Association. Xu X, Duan Z, Ding H, Li W, Jia J, Wei L, Linghu E, Zhuang H. Chinese guidelines on the management of ascites and its related complications in cirrhosis. Hepatol Int. 2019;13:1-21. [PMID: 30656520 DOI: 10.1007/s12072-018-09923-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
13 Kawaratani H, Yoshiji H. Hepatic Ascites in Liver Cirrhosis. The Evolving Landscape of Liver Cirrhosis Management 2019. [DOI: 10.1007/978-981-13-7979-6_9] [Reference Citation Analysis]
14 Shergill R, Syed W, Rizvi SA, Singh I. Nutritional support in chronic liver disease and cirrhotics. World J Hepatol 2018;10:685-94. [PMID: 30386461 DOI: 10.4254/wjh.v10.i10.685] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
15 Wang JB, Gu Y, Zhang MX, Yang S, Wang Y, Wang W, Li XR, Zhao YT, Wang HT. High expression of type I inositol 1,4,5-trisphosphate receptor in the kidney of rats with hepatorenal syndrome. World J Gastroenterol 2018; 24(29): 3273-3280 [PMID: 30090007 DOI: 10.3748/wjg.v24.i29.3273] [Reference Citation Analysis]
16 Fukui H, Kawaratani H, Kaji K, Takaya H, Yoshiji H. Management of refractory cirrhotic ascites: challenges and solutions. Hepat Med. 2018;10:55-71. [PMID: 30013405 DOI: 10.2147/hmer.s136578] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
17 Huelin P, Fortea JI, Crespo J, Fábrega E. Ascites: Treatment, Complications, and Prognosis. Ascites - Physiopathology, Treatment, Complications and Prognosis 2017. [DOI: 10.5772/intechopen.70384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Alnajjar A, Abaalkhail F, Beidas T, Abdelfattah MR, Elsiesy H. Non-pharmacological Treatment of Ascites. Ascites - Physiopathology, Treatment, Complications and Prognosis 2017. [DOI: 10.5772/intechopen.70511] [Reference Citation Analysis]
19 Fernandes SA, de Mattos AA, Tovo CV, Marroni CA. Nutritional evaluation in cirrhosis: Emphasis on the phase angle. World J Hepatol 2016;8:1205-11. [PMID: 27803765 DOI: 10.4254/wjh.v8.i29.1205] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
20 Lenz K, Buder R, Lohr G, Piringer P, Voglmayr M. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure]. Med Klin Intensivmed Notfmed 2016;111:440-6. [PMID: 27241778 DOI: 10.1007/s00063-016-0177-5] [Reference Citation Analysis]
21 Wiedermann CJ. Albumin to Reduce Mortality in Cirrhotic Patients with Acute Kidney Injury. Reducing Mortality in Acute Kidney Injury 2016. [DOI: 10.1007/978-3-319-33429-5_16] [Reference Citation Analysis]
22 Velez JC, Kadian M, Taburyanskaya M, Bohm NM, Delay TA, Karakala N, Rockey DC, Nietert PJ, Goodwin AJ, Whelan TP. Hepatorenal Acute Kidney Injury and the Importance of Raising Mean Arterial Pressure. Nephron 2015;131:191-201. [PMID: 26485256 DOI: 10.1159/000441151] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]